This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Assess the pros and cons of emergency versus sinking funds to determine which is more suitable for your goals, and how to combine them effectively.
23,964 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Direxion has unveiled SKHL, a 2X leveraged ETF tied to SK hynix, signaling a new foray into the memory-chip space. Th...
A prominent investment advisor added a sizable CMPX position, signaling strong conviction in Compass Therapeutics. He...
A standout move in the world of investing: a wealth manager makes a sizable bet on an active international rotation E...
Vanguard's Dividend Appreciation ETF (VIG) yields about 1.5% today, but behind that modest payout lies a 20-year stre...
Blackstone's flagship private-credit fund drew heavier redemptions than typical, underscoring strain in private credi...
As Treasury yields rise in 2026, CDL’s $2.29 annual dividend delivers reliable monthly cash flow from a diversified m...
Kensho Clean Power ETF (CNRG) surged 68% over the last year but fell 9% in February, as traders await a Fed signal th...
ETHA’s Spot Ethereum Promise meets a built-in constraint: the iShares Ethereum Trust cannot pass through staking rewa...
When building a portfolio, you face a choice between global exposure and an emerging markets tilt. This guide breaks ...
Analysts say Microsoft’s AI push is unlikely to threaten dividend safety inside Vanguard’s Dividend Appreciation ETF ...
A hedge fund quietly doubled down with an $8 million bet as euronet stock tanked this past year. Here’s what that mov...